We were initially incorporated in Delaware in 2005 under the name Elston Technologies, Inc. We changed our name to Biodesix, Inc. in 2006.
Biodesix went public on October 28, 2020.
Biodesix is traded on NASDAQ Exchange under the ticker symbol BDSX.
Biodesix fiscal year ends on December 31st.
Shares of Biodesix can be purchased through a broker or stock purchase service of your preference.
No, Biodesix does not have a direct stock purchase program.
The company has not paid any dividends to its stockholders since its inception and does not plan to pay any cash dividends in the foreseeable future.
The transfer agent and registrar for our common stock will be Computershare Trust Company, N.A. The transfer agent's address 150 Royall Street, Canton, Massachusetts 02021, and its telephone number is (800) 962- 4284.
Our independent registered public accountants are KPMG LLP.
Sidley Austin LLP serves as our external legal counsel.
Quarterly & Annual Reports and other investor materials are available under the SEC Filings page of the Investors section of the corporate website. Additionally, all SEC filings can also be accessed directly from the SEC website.
You can view our latest press releases, including our quarterly financial releases, on the News Releases section of our Investors website, as well as in the Newsroom on www.biodesix.com.
Company Representative:
Investor Relations at Biodesix: [email protected]
Biodesix IR partner:
Chris Brinzey, ICR Westwicke: [email protected]